Joseph Lacob
CIK: 0001215490
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (17 total)
- May 20, 2026ALGN
ALIGN TECHNOLOGY INC
Award(A)DirectRestricted Stock Units
1.8K shares- - May 20, 2026ALGN
ALIGN TECHNOLOGY INC
Exercise(M)Indirect1.7K shares- - Mar 20, 2026NPCE
NeuroPace Inc
Award(A)Direct865 shares at avg. $13.00$11K - Dec 19, 2025NPCE
NeuroPace Inc
Award(A)Direct678 shares at avg. $16.59$11K - Sep 19, 2025NPCE
NeuroPace Inc
Award(A)Direct1.1K shares at avg. $9.94$11K - Jun 21, 2025NPCE
NeuroPace Inc
Award(A)Direct1.1K shares at avg. $10.41$11K - Jun 6, 2025NPCE
NeuroPace Inc
Award(A)DirectStock Option (right to buy)
8.7K shares- - May 21, 2025ALGN
ALIGN TECHNOLOGY INC
Award(A)DirectRestricted Stock Units
1.7K shares- - May 21, 2025ALGN
ALIGN TECHNOLOGY INC
Exercise(M)Indirect1.1K shares- - Mar 21, 2025NPCE
NeuroPace Inc
Award(A)Direct935 shares at avg. $12.02$11K - Dec 21, 2024NPCE
NeuroPace Inc
Award(A)Direct975 shares at avg. $11.53$11K - Sep 30, 2024NPCE
NeuroPace Inc
Award(A)Direct1.6K shares at avg. $6.97$11K - Jun 28, 2024NPCE
NeuroPace Inc
Award(A)Direct1.5K shares at avg. $7.56$11K - Mar 29, 2024NPCE
NeuroPace Inc
Award(A)Direct852 shares at avg. $13.20$11K - Dec 29, 2023NPCE
NeuroPace Inc
Award(A)Direct1.1K shares at avg. $10.31$11K - Sep 29, 2023NPCE
NeuroPace Inc
Award(A)Direct1.2K shares at avg. $9.73$11K - Jun 30, 2023NPCE
NeuroPace Inc
Award(A)Direct2.5K shares at avg. $4.49$11K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 20, 2026 |  ALGN ALIGN TECHNOLOGY INC | Award(A) Restricted Stock Units | 1,836 | - | - | Direct |
| May 20, 2026 | ALGN ALIGN TECHNOLOGY INC | Exercise(M) | 1,745 | - | $0 | Indirect |
| Mar 20, 2026 |  NPCE NeuroPace Inc | Award(A) | 865 | $13.00 | $11,245 | Direct |
| Dec 19, 2025 | NPCE NeuroPace Inc | Award(A) | 678 | $16.59 | $11,248 | Direct |
| Sep 19, 2025 | NPCE NeuroPace Inc | Award(A) | 1,131 | $9.94 | $11,242 | Direct |
| Jun 21, 2025 | NPCE NeuroPace Inc | Award(A) | 1,080 | $10.41 | $11,243 | Direct |
| Jun 6, 2025 | NPCE NeuroPace Inc | Award(A) Stock Option (right to buy) | 8,745 | - | - | Direct |
| May 21, 2025 | ALGN ALIGN TECHNOLOGY INC | Award(A) Restricted Stock Units | 1,745 | - | - | Direct |
| May 21, 2025 | ALGN ALIGN TECHNOLOGY INC | Exercise(M) | 1,148 | - | - | Indirect |
| Mar 21, 2025 | NPCE NeuroPace Inc | Award(A) | 935 | $12.02 | $11,239 | Direct |
| Dec 21, 2024 | NPCE NeuroPace Inc | Award(A) | 975 | $11.53 | $11,242 | Direct |
| Sep 30, 2024 | NPCE NeuroPace Inc | Award(A) | 1,614 | $6.97 | $11,250 | Direct |
| Jun 28, 2024 | NPCE NeuroPace Inc | Award(A) | 1,488 | $7.56 | $11,249 | Direct |
| Mar 29, 2024 | NPCE NeuroPace Inc | Award(A) | 852 | $13.20 | $11,246 | Direct |
| Dec 29, 2023 | NPCE NeuroPace Inc | Award(A) | 1,091 | $10.31 | $11,248 | Direct |
| Sep 29, 2023 | NPCE NeuroPace Inc | Award(A) | 1,156 | $9.73 | $11,248 | Direct |
| Jun 30, 2023 | NPCE NeuroPace Inc | Award(A) | 2,505 | $4.49 | $11,247 | Direct |
1-17 of 17 transactions
About LACOB JOSEPH
LACOB JOSEPH (SEC CIK 0001215490) files insider reports with the SEC as Director of ALIGN TECHNOLOGY INC (ALGN) and Director of NeuroPace Inc (NPCE).
Signal8 holds 7 ownership filings by LACOB JOSEPH, all Form 4s, filed between May 22, 2025 and May 22, 2026. Those filings report 17 transactions, from Jun 30, 2023 to May 20, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on LACOB JOSEPH's filings is in MOUNTAIN VIEW, CA.
Recent filings by LACOB JOSEPH
- May 20, 2026: Grant or award of ALGN derivative securities (Form 4, code A).
- May 20, 2026: Option exercise of ALGN shares (Form 4, code M).
- Mar 20, 2026: Grant or award of NPCE shares (Form 4, code A).
- Dec 19, 2025: Grant or award of NPCE shares (Form 4, code A).
- Sep 19, 2025: Grant or award of NPCE shares (Form 4, code A).
Other insiders filing for ALIGN TECHNOLOGY INC (ALGN)
- Davis Jennifer L., CEO-elect
- Vitalone Britt J., Director
- SIEGEL SUSAN E, Director
- Saia Andrea Lynn, Director
- Poul Mojdeh, Director
- Myong Anne, Director